VivoSeq
Other

Psilocybin

1

Pipeline Programs↗

25

Active Trials↗

2

Companies Involved↗

Psilocybin is an early-stage landscape with 1 program across 2 companies. The most active players are COMPASS Pathways, Cybin Therapeutics Inc..

Intelligence

Pipeline Metrics

Competitive Density

40/100

Pipeline Velocity

39/100

Mech. Concentration

100/100

Completion Rate

78/100

Attrition Rate

11/100

Competition

Competitive Landscape

Bubble size = clinical trials

Approved
Phase 3
Phase 2
Phase 1
Preclinical

Key Players

Top Companies Companies ranked by the number of pipeline programs they run for this disease.

COMPASS Pathways logo

COMPASS Pathways

1 program

Phase 2C

Cybin Therapeutics Inc.

0 programs

Preclinical

Pipeline

Programs by Phase

Preclinical
No programs
Phase 1
No programs
Phase 21

Psilocybin

COMPASS Pathways

Phase 3
No programs
Approved
No programs

Analysis

Trial Status

54

clinical trials

Completed21 · 39%
Recruiting14 · 26%
Not yet recruiting7 · 13%
Withdrawn5 · 9%
Enrolling by invitation2 · 4%
Unknown status2 · 4%
Other3 · 6%

Clinical Trials

Trial Activity

54 trials

Two Doses of Psilocybin for the Treatment of MDD in Adults With Cancer
Recruiting·SSunstone Medical·Phase 2·NCT05947383·56 enrolled
Safety for Home Administration of Microdose Psilocybin Use
Recruiting·JJohns Hopkins University·Phase 1·NCT06450210·20 enrolled
Role of the Serotonin 2A Receptor in Psilocybin-induced Altered States of Consciousness
Recruiting·UUniversity Hospital, Basel, Switzerland·Phase 1·NCT06796361·16 enrolled
Direct Comparison of Altered States of Consciousness Induced by LSD, Psilocybin, and DMT in Healthy Participants
Recruiting·UUniversity Hospital, Basel, Switzerland·Phase 1·NCT06899334·24 enrolled
Safety and Psychological Effects of Psilocybin and D-Serine Formulation in Healthy Volunteers
Recruiting·HHadassah Medical Organization·Phase 1·NCT07079930·10 enrolled
State-Funded Trial Assessing Recovery and Long-Term Impact of Guided Psilocybin for Healing Trauma
Recruiting·—·Phase 2·NCT06888128·15 enrolled
Elucidating the Relevance of the Psychedelic Experience to Psilocybin's Anti-Anhedonic Effects
Recruiting·MMedical University of Vienna·Phase 1·NCT07490353·85 enrolled
Safety and Preliminary Efficacy of Organic Whole Psilocybin-Containing Mushrooms to Treat Patients Suffering From PTSD
Recruiting·SSuzanne "Sue" Sisley MD·Phase 1·NCT07275970·24 enrolled
Investigation to Understand and Optimize Psilocybin
Recruiting·—·Phase 2·NCT06512194·141 enrolled
Psilocybin-Assisted Therapy for Intergenerational Trauma
Recruiting·—·Phase 2·NCT06899165·100 enrolled
Wellcome Leap Psilocybin for OUD
Recruiting·—·Phase 2·NCT06786325·36 enrolled
Effects of Psilocybin on Electrophysiology and the Dynamic Content of Thought
Recruiting·JJohns Hopkins University·Phase 1/2·NCT05301608·30 enrolled
The RECAP2 Study: Midazolam and Psilocybin
Recruiting·UUniversity of Wisconsin, Madison·Phase 1·NCT06692192·60 enrolled
The ENHANCE Study: taVNS and Psilocybin
Recruiting·UUniversity of Wisconsin, Madison·Phase 1·NCT05866471·108 enrolled
Comparing the Effects of Psilocin and Psilocybin in Healthy Adults
Active, not recruiting·UUniversity of California, San Francisco·Phase 1·NCT05317689·20 enrolled
Page 1 of 4

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)